Publications published since 2010 from OUS - Section for Colorectal Surgery

250 publications found

Publications 2025

  1. Aune D, Nordsletten M, Myklebust TÅ, Robsahm TE, Skålhegg BS, Mala T, Yaqub S, Saeed U (2025)
    Body mass index and risk of connective and soft tissue cancer: results from a large cohort of 1.7 million individuals in Norway
    BMC Cancer, 25 (1), 243
    DOI 10.1186/s12885-025-13637-8, PubMed 39934750
  2. Aune D, Nordsletten M, Myklebust TÅ, Robsahm TE, Skålhegg BS, Mala T, Yaqub S, Saeed U (2025)
    Body mass index and risk of Hodgkin's lymphoma: Insights from a Norwegian cohort study
    Eur J Cancer, 221, 115400
    DOI 10.1016/j.ejca.2025.115400, PubMed 40228428
  3. Ericson J, Klevebro F, Sunde B, Szabo E, Halldestam I, Smedh U, Wallner B, Johansson J, Johnsen G, Aahlin EK, Johannessen HO, Hjortland GO, Lorentzen SS, Slott M, Schröder W, Rouvelas I, Nilsson M (2025)
    Nutritional outcomes and impact of malnutrition in a randomised comparison between standard and prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer
    Eur J Surg Oncol, 51 (9), 110228 (in press)
    DOI 10.1016/j.ejso.2025.110228, PubMed 40550184
  4. Hewitt S, Hofsø D, Qvigstad E, Berg TJ, Chahal-Kummen M, Kristinsson J, Mala T (2025)
    Post-bariatric hypoglycaemia
    Tidsskr Nor Laegeforen, 145 (6)
    DOI 10.4045/tidsskr.24.0396, PubMed 40366035
  5. Lie SØ, Reas DL, Mala T, Kvalem IL (2025)
    Food Addiction 5 and 10 Years Following Metabolic and Bariatric Surgery: a Prospective Observational Study
    Obes Surg, 35 (5), 1649-1656
    DOI 10.1007/s11695-025-07803-x, PubMed 40232658
  6. Saeed U, Myklebust TÅ, Robsahm TE, Aune D, Møller B, Skålhegg BS, Yaqub S, Mala T (2025)
    Associations between body mass index and gastroesophageal cancer incidence and mortality: novel insights from a nationwide registry-based cohort study
    Dis Esophagus, 38 (2)
    DOI 10.1093/dote/doaf018, PubMed 40091197
  7. Saeed U, Saunes T, Sjo OH, Schultz J (2025)
    Giant Colonic Diverticulum: Case report of a rare complication of a common disease
    Int J Surg Case Rep, 127, 110909
    DOI 10.1016/j.ijscr.2025.110909, PubMed 39930644

Publications 2024

  1. Aune D, Nordsletten M, Myklebust TÅ, Robsahm TE, Skålhegg BS, Mala T, Yaqub S, Saeed U (2024)
    The association between body mass index and vulvar and vaginal cancer incidence: findings from a large Norwegian cohort study
    Cancer Causes Control, 36 (2), 191-198
    DOI 10.1007/s10552-024-01930-z, PubMed 39463212
  2. Aune D, Nordsletten M, Myklebust TÅ, Robsahm TE, Skålhegg BS, Mala T, Yaqub S, Saeed U (2024)
    Body mass index and penile cancer incidence: results from a Norwegian cohort study of 829,081 men
    BMC Urol, 24 (1), 260
    DOI 10.1186/s12894-024-01636-z, PubMed 39605013
  3. Grønvold LAB, Mjørud Forsmo H, Pfeffer F, Norderval S, Sjo O, Brunborg C, Brudvik KW, Thomas Seeberg L (2024)
    Aggregated 1-year complication rates and health-related quality of life after reconstructive surgery for rectal cancer with or without diverting stoma (Norwegian Stoma Trial): a protocol for national multicentre, open-label, prospective cohort study
    BJS Open, 8 (1)
    DOI 10.1093/bjsopen/zrae010, PubMed 38386703
  4. Hauge T, Dretvik T, Johnson E, Mala T (2024)
    Treatment of anastomotic leakage following Ivor Lewis esophagectomy-10 year experience from a Nordic center
    Dis Esophagus, 37 (9)
    DOI 10.1093/dote/doae040, PubMed 38745429
  5. Hedberg J, Sundbom M, Edholm D, Aahlin EK, Szabo E, Lindberg F, Johnsen G, Førland DT, Johansson J, Kauppila JH, Svendsen LB, Nilsson M, Lindblad M, Lagergren P, Larsen MH, Åkesson O, Löfdahl P, Mala T, Achiam MP (2024)
    Randomized controlled trial of nasogastric tube use after esophagectomy: study protocol for the kinetic trial
    Dis Esophagus, 37 (6)
    DOI 10.1093/dote/doae010, PubMed 38366900
  6. Heieren OE, Mala T, Viktil E, Grøtta OJ, Woldbæk PR (2024)
    [Radiotherapy for lymphatic leakage]
    Tidsskr Nor Laegeforen, 144 (5)
    DOI 10.4045/tidsskr.24.0039, PubMed 38651724
  7. Heramb-Aamot J, Mala T, Fauske L (2024)
    Everyday Life Six to Eight Months After Esophagectomy for Cancer: A Qualitative Study
    Anticancer Res, 44 (2), 743-750
    DOI 10.21873/anticanres.16865, PubMed 38307550
  8. Kooij CD, de Jongh C, Kingma BF, van Berge Henegouwen MI, Gisbertz SS, Chao YK, Chiu PW, Rouanet P, Mourregot A, Immanuel A, Mala T, van Boxel GI, Carter NC, Li H, Fuchs HF, Bruns CJ, Giacopuzzi S, Kalff JC, Hölzen JP, Juratli MA, Benedix F, Lorenz E, Egberts JH, Haveman JW, van Etten B et al. (2024)
    The Current State of Robot-Assisted Minimally Invasive Esophagectomy (RAMIE): Outcomes from the Upper GI International Robotic Association (UGIRA) Esophageal Registry
    Ann Surg Oncol, 32 (2), 823-833
    DOI 10.1245/s10434-024-16364-9, PubMed 39496901
  9. Langerud J, Eilertsen IA, Moosavi SH, Klokkerud SMK, Reims HM, Backe IF, Hektoen M, Sjo OH, Jeanmougin M, Tejpar S, Nesbakken A, Lothe RA, Sveen A (2024)
    Multiregional transcriptomics identifies congruent consensus subtypes with prognostic value beyond tumor heterogeneity of colorectal cancer
    Nat Commun, 15 (1), 4342
    DOI 10.1038/s41467-024-48706-2, PubMed 38773143
  10. Lyyjynen HS, Andersen JR, Liem RSL, Mala T, Nienhuijs SW, Ottosson J, Sundbom M, Thorell A, Våge V (2024)
    Surgical Aspects of Sleeve Gastrectomy Are Related to Weight Loss and Gastro-esophageal Reflux Symptoms
    Obes Surg, 34 (3), 902-910
    DOI 10.1007/s11695-023-07018-y, PubMed 38329707
  11. Mala T, Abelseth BK, Al-Haidari G, Dørum LMR, Hatlevoll I, Rekstad LC, Stenvold H, Øvrebø KK, Aahlin EK (2024)
    [Not Available]
    Tidsskr Nor Laegeforen, 144 (15)
    DOI 10.4045/tidsskr.24.0547, PubMed 39692659
  12. Reas DL, Lie SØ, Mala T, Lundin Kvalem I (2024)
    Binge Eating Behaviour Before and 10 Years Following Metabolic and Bariatric Surgery
    Eur Eat Disord Rev, 33 (3), 544-550
    DOI 10.1002/erv.3161, PubMed 39673139
  13. Saeed U, Yaqub S, Barreto SG, Pandol S, Mala T (2024)
    Reducing the risk of cancer with bariatric surgery: The need for evidence to guide practice
    Scand J Surg, 113 (4), 332-333
    DOI 10.1177/14574969241264064, PubMed 38907591
  14. Salte OBK, Olbers T, Risstad H, Fagerland MW, Søvik TT, Blom-Høgestøl IK, Kristinsson JA, Engström M, Mala T (2024)
    Ten-Year Outcomes Following Roux-en-Y Gastric Bypass vs Duodenal Switch for High Body Mass Index: A Randomized Clinical Trial
    JAMA Netw Open, 7 (6), e2414340
    DOI 10.1001/jamanetworkopen.2024.14340, PubMed 38829616
  15. Thomassen HK, Kilander FS, Mala T, Glomsaker T, Fasting M (2024)
    [Not Available]
    Tidsskr Nor Laegeforen, 144 (7)
    DOI 10.4045/tidsskr.23.0823, PubMed 38832622
  16. Viktil E, Hanekamp BA, Nesbakken A, Løberg EM, Sjo OH, Negård A, Dormagen JB, Schulz A (2024)
    Early rectal cancer: The diagnostic performance of MRI supplemented with a rectal micro-enema and a modified staging system to identify tumors eligible for local excision
    Acta Radiol Open, 13 (5), 20584601241241523
    DOI 10.1177/20584601241241523, PubMed 38645439
  17. Viktil E, Hanekamp BA, Nesbakken A, Løberg EM, Sjo OH, Negård A, Dormagen JB, Schulz A (2024)
    MRI of early rectal cancer; bisacodyl micro-enema increases submucosal width, reader confidence, and tumor conspicuity
    Abdom Radiol (NY), 50 (6), 2401-2413
    DOI 10.1007/s00261-024-04701-1, PubMed 39645641
  18. Visser MR, Voeten DM, Gisbertz SS, Ruurda JP, Achiam MP, Nilsson M, Markar SR, Pera M, Rosati R, Piessen G, Nafteux P, Gutschow CA, Grimminger PP, Räsänen JV, Reynolds JV, Johannessen HO, Vieira P, Weitzendorfer M, Kechagias A, van Berge Henegouwen MI, van Hillegersberg R (2024)
    Western European Variation in the Organization of Esophageal Cancer Surgical Care
    Dis Esophagus, 37 (9)
    DOI 10.1093/dote/doae033, PubMed 38670807

Publications 2023

  1. Anundsen TK, Førland DT, Johannessen HO, Johnson E (2023)
    Outcome after stent and endoscopic vacuum therapy-based treatment for postemetic esophageal rupture
    Scand J Gastroenterol, 59 (1), 1-6
    DOI 10.1080/00365521.2023.2248537, PubMed 37592384
  2. Blom-Høgestøl IK, Aasbrenn M, Kvalem IL, Eribe I, Kristinsson JA, Mala T (2023)
    Pain sensitivity after Roux-en-Y gastric bypass - associations with chronic abdominal pain and psychosocial aspects
    Scand J Pain, 23 (3), 511-517
    DOI 10.1515/sjpain-2023-0005, PubMed 37306001
  3. Chahal-Kummen M, Våge V, Kristinsson JA, Mala T (2023)
    Chronic abdominal pain and quality of life after Roux-en-Y gastric bypass and sleeve gastrectomy - a cross-cohort analysis of two prospective longitudinal observational studies
    Surg Obes Relat Dis, 19 (8), 819-829
    DOI 10.1016/j.soard.2023.01.020, PubMed 36870870
  4. de Jongh C, Cianchi F, Kinoshita T, Kingma F, Piccoli M, Dubecz A, Kouwenhoven E, van Det M, Mala T, Coratti A, Ubiali P, Turner P, Kish P, Borghi F, Immanuel A, Nilsson M, Rouvelas I, Hӧlzen JP, Rouanet P, Saint-Marc O, Dussart D, Patriti A, Bazzocchi F, van Etten B, Haveman JW et al. (2023)
    Surgical Techniques and Related Perioperative Outcomes After Robot-assisted Minimally Invasive Gastrectomy (RAMIG): Results From the Prospective Multicenter International Ugira Gastric Registry
    Ann Surg, 280 (1), 98-107
    DOI 10.1097/SLA.0000000000006147, PubMed 37922237
  5. Fasting MH, Strønen E, Glomsaker T, Søvik TT, Fyhn TJ, Mala T (2023)
    Perioperative strategies for patients undergoing subtotal cholecystectomy: a single-center retrospective review of 102 procedures
    Scand J Gastroenterol, 59 (4), 456-460
    DOI 10.1080/00365521.2023.2289352, PubMed 38053273
  6. Kazaryan AM, Monrad-Hansen PW, Eftang LL, Hagve M, Nedrebø BS, Rancinger P, Mala T (2023)
    Perioperative antibiotic prophylaxis and interval appendectomy
    Tidsskr Nor Laegeforen, 143 (7)
    DOI 10.4045/tidsskr.23.0282, PubMed 37158527
  7. Kvaerner AS, Andersen AR, Henriksen HB, Knudsen MD, Johansen AMW, Hjartåker A, Bøhn SK, Paur I, Wiedswang G, Smeland S, Rounge TB, Blomhoff R, Berstad P (2023)
    Associations of the 2018 World Cancer Research Fund/American Institute of Cancer Research (WCRF/AICR) cancer prevention recommendations with stages of colorectal carcinogenesis
    Cancer Med, 12 (13), 14806-14819
    DOI 10.1002/cam4.6119, PubMed 37212529
  8. Mala T (2023)
    Abdominal pain: A foe in the orchestra of improving symptoms after Roux-en-Y gastric bypass surgery
    Clin Obes, 13 (5), e12582
    DOI 10.1111/cob.12582, PubMed 36727223
  9. Mala T, Yaqub S, Saeed U (2023)
    [Reduced cancer risk after bariatric surgery]
    Tidsskr Nor Laegeforen, 143 (13)
    DOI 10.4045/tidsskr.23.0501, PubMed 37753764
  10. Mala T, Aahlin EK (2023)
    Stepping up the management of anastomotic leaks after oesophagectomy: getting a feel through less invasive tentacles
    Br J Surg, 110 (8), 877-879
    DOI 10.1093/bjs/znad142, PubMed 37279917
  11. Nilsson K, Klevebro F, Sunde B, Rouvelas I, Lindblad M, Szabo E, Halldestam I, Smedh U, Wallner B, Johansson J, Johnsen G, Aahlin EK, Johannessen HO, Alexandersson von Döbeln G, Hjortland GO, Wang N, Shang Y, Borg D, Quaas A, Bartella I, Bruns C, Schröder W, Nilsson M (2023)
    Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trial
    Ann Oncol, 34 (11), 1015-1024
    DOI 10.1016/j.annonc.2023.08.010, PubMed 37657554
  12. Nordsletten M, Saeed U, Myklebust TÅ, Robsahm TE, Møller B, Skålhegg BS, Mala T, Yaqub S (2023)
    Body mass index and its association with 22 cancer types: a Norwegian cohort study of 481 202 cancer cases
    Acta Oncol, 62 (10), 1273-1278
    DOI 10.1080/0284186X.2023.2258443, PubMed 37713274
  13. Richardsen AJ, Chahal-Kummen M, Kristinsson JA, Søvik TT, Eribe IEL, Mala T (2023)
    Single anastomosis gastric bypass for morbid obesity
    Tidsskr Nor Laegeforen, 143 (16)
    DOI 10.4045/tidsskr.23.0070, PubMed 37938008
  14. Saeed U, Nordsletten M, Myklebust TÅ, Robsahm TE, Møller B, Skålhegg BS, Mala T, Yaqub S (2023)
    Cancer risk and survival according to body mass index in hepatobiliary malignancies: a nationwide registry-based cohort study
    HPB (Oxford), 25 (11), 1382-1392
    DOI 10.1016/j.hpb.2023.07.882, PubMed 37544854

Publications 2022

  1. Bergsland CH, Jeanmougin M, Moosavi SH, Svindland A, Bruun J, Nesbakken A, Sveen A, Lothe RA (2022)
    Spatial analysis and CD25-expression identify regulatory T cells as predictors of a poor prognosis in colorectal cancer
    Mod Pathol, 35 (9), 1236-1246
    DOI 10.1038/s41379-022-01086-8, PubMed 35484226
  2. Buer L, Kvalem IL, Bårdstu S, Mala T (2022)
    Comparing Bariatric Surgery Patients Who Desire, Have Undergone, or Have No Desire for Body Contouring Surgery: a 5-Year Prospective Study of Body Image and Mental Health
    Obes Surg, 32 (9), 2952-2959
    DOI 10.1007/s11695-022-06117-6, PubMed 35739416
  3. Hauge T, Førland DT, Johannessen HO, Johnson E (2022)
    Short- and long-term outcomes in patients operated with total minimally invasive esophagectomy for esophageal cancer
    Dis Esophagus, 35 (5)
    DOI 10.1093/dote/doab061, PubMed 34491299
  4. Kazaryan AM, Eftang LL, Ødegaard P, Hagve M, Skjold-Ødegaard B, Olsen OC, Sharapova SA, Breuer RG, Vinge-Holmquist O, Malik YG, Wiborg J, Grønvold LB, Monrad-Hansen PW, Nobæk S, Butt K, Wasmuth HH, Nedrebø BS, Trondsen E, Rancinger P, Mala T, Søreide K (2022)
    The treatment of appendicitis should be standardised
    Tidsskr Nor Laegeforen, 142 (11)
    DOI 10.4045/tidsskr.22.0232, PubMed 35997195
  5. Kleppe A, Skrede OJ, De Raedt S, Hveem TS, Askautrud HA, Jacobsen JE, Church DN, Nesbakken A, Shepherd NA, Novelli M, Kerr R, Liestøl K, Kerr DJ, Danielsen HE (2022)
    A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation study
    Lancet Oncol, 23 (9), 1221-1232
    DOI 10.1016/S1470-2045(22)00391-6, PubMed 35964620
  6. Mala T, Førland D, Skagemo C, Glomsaker T, Johannessen HO, Johnson E (2022)
    Early experience with total robotic D2 gastrectomy in a low incidence region: surgical perspectives
    BMC Surg, 22 (1), 137
    DOI 10.1186/s12893-022-01576-1, PubMed 35397558
  7. Mala T, Søvik TT, Kristinsson J (2022)
    [Gastroscopy following vertical sleeve gastrectomy for morbid obesity]
    Tidsskr Nor Laegeforen, 142 (7)
    DOI 10.4045/tidsskr.22.0056, PubMed 35510465
  8. Nilssen Y, Brustugun OT, Eriksen MT, Guren MG, Haug ES, Naume B, Schlichting E, Møller B (2022)
    Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015-2016
    BMC Cancer, 22 (1), 220
    DOI 10.1186/s12885-022-09306-9, PubMed 35227226
  9. Pinto R, Hauge T, Jeanmougin M, Pharo HD, Kresse SH, Honne H, Winge SB, Five MB, Kumar T, Mala T, Hauge T, Johnson E, Lind GE (2022)
    Targeted genetic and epigenetic profiling of esophageal adenocarcinomas and non-dysplastic Barrett's esophagus
    Clin Epigenetics, 14 (1), 77
    DOI 10.1186/s13148-022-01287-7, PubMed 35701814
  10. Saeed U, Myklebust TÅ, Robsahm TE, Kielland MF, Møller B, Skålhegg BS, Mala T, Yaqub S (2022)
    Risk and survival in colorectal cancer with increasing body mass index: A nationwide population-based cohort study
    Colorectal Dis, 25 (3), 375-385
    DOI 10.1111/codi.16367, PubMed 36222384
  11. Saeed U, Myklebust TÅ, Robsahm TE, Møller B, Mala T, Skålhegg BS, Yaqub S (2022)
    Body mass index and pancreatic adenocarcinoma: A nationwide registry-based cohort study
    Scand J Surg, 112 (1), 11-21
    DOI 10.1177/14574969221127530, PubMed 36173093

Publications 2021

  1. Alavi DH, Henriksen HB, Lauritzen PM, Kværner AS, Sakinis T, Langleite TM, Henriksen C, Bøhn SK, Paur I, Wiedswang G, Smeland S, Blomhoff R (2021)
    Quantification of adipose tissues by Dual-Energy X-Ray Absorptiometry and Computed Tomography in colorectal cancer patients
    Clin Nutr ESPEN, 43, 360-368
    DOI 10.1016/j.clnesp.2021.03.022, PubMed 34024541
  2. Arnold M, Morgan E, Bardot A, Rutherford MJ, Ferlay J, Little A, Møller B, Bucher O, De P, Woods RR, Saint-Jacques N, Gavin AT, Engholm G, Achiam MP, Porter G, Walsh PM, Vernon S, Kozie S, Ramanakumar AV, Lynch C, Harrison S, Merrett N, O'Connell DL, Mala T, Elwood M et al. (2021)
    International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study)
    Gut, 71 (8), 1532-1543
    DOI 10.1136/gutjnl-2021-325266, PubMed 34824149
  3. Berg KCG, Brunsell TH, Sveen A, Alagaratnam S, Bjørnslett M, Hektoen M, Brudvik KW, Røsok BI, Bjørnbeth BA, Nesbakken A, Lothe RA (2021)
    Genomic and prognostic heterogeneity among RAS/BRAFV600E /TP53 co-mutated resectable colorectal liver metastases
    Mol Oncol, 15 (4), 830-845
    DOI 10.1002/1878-0261.12885, PubMed 33325154
  4. Bruun J, Eide PW, Bergsland CH, Bruck O, Svindland A, Arjama M, Välimäki K, Bjørnslett M, Guren MG, Kallioniemi O, Nesbakken A, Lothe RA, Pellinen T (2021)
    E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models
    Mol Oncol, 16 (12), 2312-2329
    DOI 10.1002/1878-0261.13159, PubMed 34890102
  5. Chahal-Kummen M, Nordahl M, Våge V, Blom-Høgestøl I, Kristinsson JA, Mala T (2021)
    A prospective longitudinal study of chronic abdominal pain and symptoms after sleeve gastrectomy
    Surg Obes Relat Dis, 17 (12), 2054-2064
    DOI 10.1016/j.soard.2021.07.014, PubMed 34518144
  6. Eide PW, Moosavi SH, Eilertsen IA, Brunsell TH, Langerud J, Berg KCG, Røsok BI, Bjørnbeth BA, Nesbakken A, Lothe RA, Sveen A (2021)
    Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer
    NPJ Genom Med, 6 (1), 59
    DOI 10.1038/s41525-021-00223-7, PubMed 34262039
  7. Haug HM, Carlsen E, Johannessen HO, Johnson E (2021)
    Short-, long-, and very long-term results of secondary anterior sphincteroplasty in 20 patients with obstetric injury
    Int J Colorectal Dis, 36 (12), 2775-2778
    DOI 10.1007/s00384-021-04026-1, PubMed 34528117
  8. Henriksen C, Paur I, Pedersen A, Kværner AS, Ræder H, Henriksen HB, Bøhn SK, Wiedswang G, Blomhoff R (2021)
    Agreement between GLIM and PG-SGA for diagnosis of malnutrition depends on the screening tool used in GLIM
    Clin Nutr, 41 (2), 329-336
    DOI 10.1016/j.clnu.2021.12.024, PubMed 34999327
  9. Hugenschmidt H, Labori KJ, Borgen E, Brunborg C, Schirmer CB, Seeberg LT, Naume B, Wiedswang G (2021)
    Preoperative CTC-Detection by CellSearch® Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer
    Cancers (Basel), 13 (3)
    DOI 10.3390/cancers13030485, PubMed 33513877
  10. Kleive D, Aas E, Angelsen JH, Bringeland EA, Nesbakken A, Nymo LS, Schultz JK, Søreide K, Yaqub S (2021)
    Simultaneous Resection of Primary Colorectal Cancer and Synchronous Liver Metastases: Contemporary Practice, Evidence and Knowledge Gaps
    Oncol Ther, 9 (1), 111-120
    DOI 10.1007/s40487-021-00148-2, PubMed 33759076
  11. Kryeziu K, Moosavi SH, Bergsland CH, Guren MG, Eide PW, Totland MZ, Lassen K, Abildgaard A, Nesbakken A, Sveen A, Lothe RA (2021)
    Increased sensitivity to SMAC mimetic LCL161 identified by longitudinal ex vivo pharmacogenomics of recurrent, KRAS mutated rectal cancer liver metastases
    J Transl Med, 19 (1), 384
    DOI 10.1186/s12967-021-03062-3, PubMed 34496878
  12. Mala T (2021)
    Finding the sweet spot in the surgical treatment of diabetes in obesity
    Br J Surg, 108 (9), 1011-1013
    DOI 10.1093/bjs/znab179, PubMed 33914072
  13. Mala T, Chahal-Kummen M, Kristinsson J (2021)
    Letter to the Editor
    Obes Surg, 31 (12), 5459
    DOI 10.1007/s11695-021-05523-6, PubMed 34165667
  14. Moosavi SH, Eide PW, Eilertsen IA, Brunsell TH, Berg KCG, Røsok BI, Brudvik KW, Bjørnbeth BA, Guren MG, Nesbakken A, Lothe RA, Sveen A (2021)
    De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity
    Genome Med, 13 (1), 143
    DOI 10.1186/s13073-021-00956-1, PubMed 34470666
  15. Nilssen Y, Eriksen MT, Guren MG, Møller B (2021)
    Factors associated with emergency-onset diagnosis, time to treatment and type of treatment in colorectal cancer patients in Norway
    BMC Cancer, 21 (1), 757
    DOI 10.1186/s12885-021-08415-1, PubMed 34187404
  16. Salte OBK, Svanevik M, Risstad H, Hofsø D, Blom-Høgestøl IK, Johnson LK, Fagerland MW, Kristinsson J, Hjelmesæth J, Mala T, Sandbu R (2021)
    Standard versus distal Roux-en-Y gastric bypass in patients with BMI 50-60 kg/m2: 5-year outcomes of a double-blind, randomized clinical trial
    BJS Open, 5 (6)
    DOI 10.1093/bjsopen/zrab105, PubMed 34791048
  17. Skjold-Odegaard B, Ersdal HL, Assmus J, Nedrebo BSO, Sjo O, Soreide K (2021)
    Development and clinical implementation of a structured, simulation-based training programme in laparoscopic appendectomy: description, validation and evaluation
    BMJ Simul Technol Enhanc Learn, 7 (6), 517-523
    DOI 10.1136/bmjstel-2020-000728, PubMed 35520958
  18. Slørdahl KS, Klotz D, Olsen JÅ, Skovlund E, Undseth C, Abildgaard HL, Brændengen M, Nesbakken A, Larsen SG, Hanekamp BA, Holmboe L, Tvedt R, Sveen A, Lothe RA, Malinen E, Kaasa S, Guren MG (2021)
    Treatment outcomes and prognostic factors after chemoradiotherapy for anal cancer
    Acta Oncol, 60 (7), 921-930
    DOI 10.1080/0284186X.2021.1918763, PubMed 33966592
  19. Sveen A, Johannessen B, Eilertsen IA, Røsok BI, Gulla M, Eide PW, Bruun J, Kryeziu K, Meza-Zepeda LA, Myklebost O, Bjørnbeth BA, Skotheim RI, Nesbakken A, Lothe RA (2021)
    The expressed mutational landscape of microsatellite stable colorectal cancers
    Genome Med, 13 (1), 142
    DOI 10.1186/s13073-021-00955-2, PubMed 34470667

Publications 2020

  1. Bergsland CH, Bruun J, Guren MG, Svindland A, Bjørnslett M, Smeby J, Hektoen M, Kolberg M, Domingo E, Pellinen T, Tomlinson I, Kerr D, Church DN, Nesbakken A, Sveen A, Lothe RA (2020)
    Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer
    ESMO Open, 5 (6), e001040
    DOI 10.1136/esmoopen-2020-001040, PubMed 33219056
  2. Bruun J, Kryeziu K, Eide PW, Moosavi SH, Eilertsen IA, Langerud J, Røsok B, Totland MZ, Brunsell TH, Pellinen T, Saarela J, Bergsland CH, Palmer HG, Brudvik KW, Guren T, Dienstmann R, Guren MG, Nesbakken A, Bjørnbeth BA, Sveen A, Lothe RA (2020)
    Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity
    Clin Cancer Res, 26 (15), 4107-4119
    DOI 10.1158/1078-0432.CCR-19-3637, PubMed 32299813
  3. Butler J, Finley C, Norell CH, Harrison S, Bryant H, Achiam MP, Altman AD, Baxter N, Bentley J, Cohen PA, Chaudry MA, Dixon E, Farrell R, Fegan S, Hashmi S, Hogdall C, Jenkins JT, Kwon J, Mala T, McNally O, Merrett N, Nelson G, Nordin A, Park J, Porter G et al. (2020)
    New approaches to cancer care in a COVID-19 world
    Lancet Oncol, 21 (7), e339-e340
    DOI 10.1016/S1470-2045(20)30340-5, PubMed 32615112
  4. Bärebring L, Kværner AS, Skotnes M, Henriksen HB, Skjetne AJ, Henriksen C, Ræder H, Paur I, Bøhn SK, Wiedswang G, Smeland S, Blomhoff R (2020)
    Use of bioelectrical impedance analysis to monitor changes in fat-free mass during recovery from colorectal cancer- a validation study
    Clin Nutr ESPEN, 40, 201-207
    DOI 10.1016/j.clnesp.2020.09.021, PubMed 33183537
  5. Chahal-Kummen M, Salte OBK, Hewitt S, Blom-Høgestøl IK, Risstad H, Kristinsson J, Mala T (2020)
    Health benefits and risks during 10 years after Roux-en-Y gastric bypass
    Surg Endosc, 34 (12), 5368-5376
    DOI 10.1007/s00464-019-07328-2, PubMed 31993812
  6. Durbeck A, Johannessen HO, Drolsum A, Johnson E (2020)
    Very long-term outcome after resection rectopexy for internal rectal intussusception
    Scand J Gastroenterol, 56 (1), 122-127
    DOI 10.1080/00365521.2020.1853221, PubMed 33253596
  7. Gharagozlian S, Mala T, Brekke HK, Kolbjørnsen LC, Ullerud ÅA, Johnson E (2020)
    Nutritional status, sarcopenia, gastrointestinal symptoms and quality of life after gastrectomy for cancer - A cross-sectional pilot study
    Clin Nutr ESPEN, 37, 195-201
    DOI 10.1016/j.clnesp.2020.03.001, PubMed 32359743
  8. Hauge T, Amdal CD, Falk RS, Johannessen HO, Johnson E (2020)
    Long-term outcome in patients operated with hybrid esophagectomy for esophageal cancer - a cohort study
    Acta Oncol, 59 (7), 859-865
    DOI 10.1080/0284186X.2020.1750694, PubMed 32324079
  9. Hauge T, Franco-Lie I, Løberg EM, Hauge T, Johnson E (2020)
    Outcome after endoscopic treatment for dysplasia and superficial esophageal cancer - a cohort study
    Scand J Gastroenterol, 55 (9), 1132-1138
    DOI 10.1080/00365521.2020.1800813, PubMed 32748653
  10. Helland T, Naume B, Hustad S, Bifulco E, Kvaløy JT, Saetersdal AB, Synnestvedt M, Lende TH, Gilje B, Mjaaland I, Weyde K, Blix ES, Wiedswang G, Borgen E, Hertz DL, Janssen EAM, Mellgren G, Søiland H (2020)
    Low Z-4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen
    Mol Oncol, 15 (4), 957-967
    DOI 10.1002/1878-0261.12865, PubMed 33252186
  11. Hetland G, Johnson E, Bernardshaw SV, Grinde B (2020)
    Can medicinal mushrooms have prophylactic or therapeutic effect against COVID-19 and its pneumonic superinfection and complicating inflammation?
    Scand J Immunol, 93 (1), e12937
    DOI 10.1111/sji.12937, PubMed 32657436
  12. Hetland G, Tangen JM, Mahmood F, Mirlashari MR, Nissen-Meyer LSH, Nentwich I, Therkelsen SP, Tjønnfjord GE, Johnson E (2020)
    Antitumor, Anti-Inflammatory and Antiallergic Effects of Agaricus blazei Mushroom Extract and the Related Medicinal Basidiomycetes Mushrooms, Hericium erinaceus and Grifola frondosa: A Review of Preclinical and Clinical Studies
    Nutrients, 12 (5)
    DOI 10.3390/nu12051339, PubMed 32397163
  13. Hewitt S, Kristinsson J, Aasheim ET, Blom-Høgestøl IK, Aaseth E, Jahnsen J, Eriksen EF, Mala T (2020)
    Relationships Between Vitamin D Status and PTH over 5 Years After Roux-en-Y Gastric Bypass: a Longitudinal Cohort Study
    Obes Surg, 30 (9), 3426-3434
    DOI 10.1007/s11695-020-04582-5, PubMed 32306297
  14. Hugenschmidt H, Labori KJ, Brunborg C, Verbeke CS, Seeberg LT, Bendigtsen Schirmer C, Renolen A, Borgen E, Naume B, Wiedswang G (2020)
    Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information
    BMC Cancer, 20 (1), 1107
    DOI 10.1186/s12885-020-07510-z, PubMed 33198661
  15. Hugenschmidt H, Labori KJ, Brunborg C, Verbeke CS, Seeberg LT, Schirmer CB, Renolen A, Borgen EF, Naume B, Wiedswang G (2020)
    Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma
    Ann Surg, 271 (3), 549-558
    DOI 10.1097/SLA.0000000000003035, PubMed 30216219
  16. Kazaryan AM, Warberg EA, Mala T (2020)
    Surgery for Appendicitis: Where Do We Go? Rational Imaging and Surgical Approach
    World J Surg, 44 (9), 2974-2975
    DOI 10.1007/s00268-020-05594-z, PubMed 32440954
  17. Kværner AS, Harnæs H, Alavi DH, Bärebring L, Henriksen HB, Guren MG, Lauritzen PM, Eggesbø HB, Wiedswang G, Smeland S, Blomhoff R (2020)
    Should calculation of chemotherapy dosage for bowel cancer be based on body composition?
    Tidsskr Nor Laegeforen, 140 (8)
    DOI 10.4045/tidsskr.19.0769, PubMed 32463187
  18. Nilssen Y, Brustugun OT, Eriksen MT, Haug ES, Naume B, Møller B (2020)
    Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016
    BMC Cancer, 20 (1), 488
    DOI 10.1186/s12885-020-06979-y, PubMed 32473650
  19. Nilsson K, Klevebro F, Rouvelas I, Lindblad M, Szabo E, Halldestam I, Smedh U, Wallner B, Johansson J, Johnsen G, Aahlin EK, Johannessen HO, Hjortland GO, Bartella I, Schröder W, Bruns C, Nilsson M (2020)
    Surgical Morbidity and Mortality From the Multicenter Randomized Controlled NeoRes II Trial: Standard Versus Prolonged Time to Surgery After Neoadjuvant Chemoradiotherapy for Esophageal Cancer
    Ann Surg, 272 (5), 684-689
    DOI 10.1097/SLA.0000000000004340, PubMed 32833767
  20. Poelemeijer YQM, Liem RSL, Våge V, Mala T, Sundbom M, Ottosson J, Nienhuijs SW (2020)
    Gastric Bypass Versus Sleeve Gastrectomy: Patient Selection and Short-term Outcome of 47,101 Primary Operations From the Swedish, Norwegian, and Dutch National Quality Registries
    Ann Surg, 272 (2), 326-333
    DOI 10.1097/SLA.0000000000003279, PubMed 32675546
  21. Safi N, Johannessen HO, Medhus AW, Mala T, Kazmi SSH (2020)
    Laser Doppler Flowmetry and Visible Light Spectroscopy of the Gastric Tube During Minimally Invasive Esophagectomy
    Vasc Health Risk Manag, 16, 497-505
    DOI 10.2147/VHRM.S269138, PubMed 33273819
  22. Skrede OJ, De Raedt S, Kleppe A, Hveem TS, Liestøl K, Maddison J, Askautrud HA, Pradhan M, Nesheim JA, Albregtsen F, Farstad IN, Domingo E, Church DN, Nesbakken A, Shepherd NA, Tomlinson I, Kerr R, Novelli M, Kerr DJ, Danielsen HE (2020)
    Deep learning for prediction of colorectal cancer outcome: a discovery and validation study
    Lancet, 395 (10221), 350-360
    DOI 10.1016/S0140-6736(19)32998-8, PubMed 32007170
  23. Smeby J, Kryeziu K, Berg KCG, Eilertsen IA, Eide PW, Johannessen B, Guren MG, Nesbakken A, Bruun J, Lothe RA, Sveen A (2020)
    Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity
    EBioMedicine, 59, 102923
    DOI 10.1016/j.ebiom.2020.102923, PubMed 32799124
  24. Tønnesen CJ, Young J, Glomsaker T, Mala T, Løberg M, Bretthauer M, Refsum E, Aabakken L (2020)
    Laparoscopy-assisted versus balloon enteroscopy-assisted ERCP after Roux-en-Y gastric bypass
    Endoscopy, 52 (8), 654-661
    DOI 10.1055/a-1139-9313, PubMed 32316042

Publications 2019

  1. Berg KCG, Sveen A, Høland M, Alagaratnam S, Berg M, Danielsen SA, Nesbakken A, Søreide K, Lothe RA (2019)
    Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains
    Oncogene, 38 (33), 6109-6122
    DOI 10.1038/s41388-019-0868-5, PubMed 31308487
  2. Blom-Høgestøl IK, Mala T, Kristinsson JA, Hauge EM, Brunborg C, Gulseth HL, Eriksen EF (2019)
    Changes in Bone Marrow Adipose Tissue One Year After Roux-en-Y Gastric Bypass: A Prospective Cohort Study
    J Bone Miner Res, 34 (10), 1815-1823
    DOI 10.1002/jbmr.3814, PubMed 31216081
  3. Blom-Høgestøl IK, Aasbrenn M, Chahal-Kummen M, Brunborg C, Eribe I, Kristinsson J, Farup PG, Mala T (2019)
    Irritable bowel syndrome-like symptoms and health related quality of life two years after Roux-en-Y gastric bypass - a prospective cohort study
    BMC Gastroenterol, 19 (1), 204
    DOI 10.1186/s12876-019-1103-0, PubMed 31791249
  4. Brunsell TH, Cengija V, Sveen A, Bjørnbeth BA, Røsok BI, Brudvik KW, Guren MG, Lothe RA, Abildgaard A, Nesbakken A (2019)
    Heterogeneous radiological response to neoadjuvant therapy is associated with poor prognosis after resection of colorectal liver metastases
    Eur J Surg Oncol, 45 (12), 2340-2346
    DOI 10.1016/j.ejso.2019.07.017, PubMed 31350075
  5. Brunsell TH, Sveen A, Bjørnbeth BA, Røsok BI, Danielsen SA, Brudvik KW, Berg KCG, Johannessen B, Cengija V, Abildgaard A, Guren MG, Nesbakken A, Lothe RA (2019)
    High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases
    Clin Colorectal Cancer, 19 (1), e26-e47
    DOI 10.1016/j.clcc.2019.09.003, PubMed 31982351
  6. Chahal-Kummen M, Blom-Høgestøl IK, Eribe I, Klungsøyr O, Kristinsson J, Mala T (2019)
    Abdominal pain and symptoms before and after Roux-en-Y gastric bypass
    BJS Open, 3 (3), 317-326
    DOI 10.1002/bjs5.50148, PubMed 31183448
  7. Dienstmann R, Villacampa G, Sveen A, Mason MJ, Niedzwiecki D, Nesbakken A, Moreno V, Warren RS, Lothe RA, Guinney J (2019)
    Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer
    Ann Oncol, 30 (10), 1622-1629
    DOI 10.1093/annonc/mdz287, PubMed 31504112
  8. Eilertsen IA, Moosavi SH, Strømme JM, Nesbakken A, Johannessen B, Lothe RA, Sveen A (2019)
    Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer
    Cancer Lett, 469, 246-255
    DOI 10.1016/j.canlet.2019.10.040, PubMed 31678167
  9. Glaire MA, Domingo E, Sveen A, Bruun J, Nesbakken A, Nicholson G, Novelli M, Lawson K, Oukrif D, Kildal W, Danielsen HE, Kerr R, Kerr D, Tomlinson I, Lothe RA, Church DN (2019)
    Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage
    Br J Cancer, 121 (6), 474-482
    DOI 10.1038/s41416-019-0540-4, PubMed 31388185
  10. Glaire MA, Domingo E, Sveen A, Bruun J, Nesbakken A, Nicholson G, Novelli M, Lawson K, Oukrif D, Kildal W, Danielsen HE, Kerr R, Kerr D, Tomlinson I, Lothe RA, Church DN (2019)
    Correction: Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage
    Br J Cancer, 121 (9), 807
    DOI 10.1038/s41416-019-0590-7, PubMed 31548598
  11. Hauge T, Kleven OC, Johnson E, Hofstad B, Johannessen HO (2019)
    Outcome after iatrogenic esophageal perforation
    Scand J Gastroenterol, 54 (2), 140-144
    DOI 10.1080/00365521.2019.1575464, PubMed 30857441
  12. Johnson E, Therkelsen SP, Nentwich I, Nissen-Meyer LSH, Hetland G (2019)
    IgE-sensitization to food and inhalant allergens in IBD patients compared with normal blood donors at Oslo University Hospital, Norway
    Scand J Gastroenterol, 54 (9), 1107-1110
    DOI 10.1080/00365521.2019.1663445, PubMed 31524013
  13. Joranger P, Nesbakken A, Sorbye H, Hoff G, Oshaug A, Aas E (2019)
    Survival and costs of colorectal cancer treatment and effects of changing treatment strategies: a model approach
    Eur J Health Econ, 21 (3), 321-334
    DOI 10.1007/s10198-019-01130-6, PubMed 31707584
  14. Kvalem IL, Bårdstu S, Bergh I, Nordvik T, Sogg S, Mala T (2019)
    Associations between perceived somatic symptoms and mental health after Roux-en-Y gastric bypass: a 3-year prospective cohort study
    Surg Obes Relat Dis, 16 (5), 626-632
    DOI 10.1016/j.soard.2019.12.018, PubMed 32007433
  15. Lopes N, Bergsland CH, Bjørnslett M, Pellinen T, Svindland A, Nesbakken A, Almeida R, Lothe RA, David L, Bruun J (2019)
    Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2
    Lab Invest, 100 (1), 120-134
    DOI 10.1038/s41374-019-0336-4, PubMed 31641225
  16. Mansoor SM, Våpenstad C, Mårvik R, Glomsaker T, Bliksøen M (2019)
    Construct validity of eoSim - a low-cost and portable laparoscopic simulator
    Minim Invasive Ther Allied Technol, 29 (5), 261-268
    DOI 10.1080/13645706.2019.1638411, PubMed 31280633
  17. Salte OB, Sovik TT, Risstad H, Skattum J, Blom-Hogestol IK, Eribe IEL, Kristinsson JA, Mala T (2019)
    Bariatric surgery at Oslo University Hospital 2004-14
    Tidsskr. Nor. Laegeforen., 139 (10), 921-926
  18. Salte OB, Søvik TT, Risstad H, Skattum J, Blom-Høgestøl IK, Eribe IEL, Kristinsson JA, Mala T (2019)
    [Bariatric surgery at Oslo University Hospital 2004–14]
    Tidsskr Nor Laegeforen, 139 (10)
    DOI 10.4045/tidsskr.18.0495, PubMed 31238674
  19. Smeby J, Sveen A, Bergsland CH, Eilertsen IA, Danielsen SA, Eide PW, Hektoen M, Guren MG, Nesbakken A, Bruun J, Lothe RA (2019)
    Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancer
    ESMO Open, 4 (3), e000523
    DOI 10.1136/esmoopen-2019-000523, PubMed 31321083
  20. Smeby J, Sveen A, Eilertsen IA, Danielsen SA, Hoff AM, Eide PW, Johannessen B, Hektoen M, Skotheim RI, Guren MG, Nesbakken A, Lothe RA (2019)
    Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer
    Oncogenesis, 8 (6), 35
    DOI 10.1038/s41389-019-0141-3, PubMed 31092812
  21. Svanevik M, Risstad H, Hofsø D, Blom-Høgestøl IK, Kristinsson JA, Sandbu R, Småstuen MC, Thorsby PM, Mala T, Hjelmesæth J (2019)
    Bone Turnover Markers After Standard and Distal Roux-en-Y Gastric Bypass: Results from a Randomized Controlled Trial
    Obes Surg, 29 (9), 2886-2895
    DOI 10.1007/s11695-019-03909-1, PubMed 31065919
  22. von Döbeln GA, Klevebro F, Jacobsen AB, Johannessen HO, Nielsen NH, Johnsen G, Hatlevoll I, Glenjen NI, Friesland S, Lundell L, Yu J, Nilsson M (2019)
    Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial
    Dis Esophagus, 32 (2)
    DOI 10.1093/dote/doy078, PubMed 30137281
  23. Wasmuth HH, Faerden AE, Myklebust TÅ, Pfeffer F, Norderval S, Riis R, Olsen OC, Lambrecht JR, Kørner H, Larsen SG, Norwegian TaTME Collaborative Group, on behalf of the Norwegian Colorectal Cancer Group, Forsmo HM, Baekkelund O, Lavik S, Knapp JC, Sjo O, Rashid G (2019)
    Transanal total mesorectal excision for rectal cancer has been suspended in Norway
    Br J Surg, 107 (1), 121-130
    DOI 10.1002/bjs.11459, PubMed 31802481

Publications 2018

  1. Bruun J, Sveen A, Barros R, Eide PW, Eilertsen I, Kolberg M, Pellinen T, David L, Svindland A, Kallioniemi O, Guren MG, Nesbakken A, Almeida R, Lothe RA (2018)
    Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer
    Mol Oncol, 12 (9), 1639-1655
    DOI 10.1002/1878-0261.12347, PubMed 29900672
  2. Danielsen HE, Hveem TS, Domingo E, Pradhan M, Kleppe A, Syvertsen RA, Kostolomov I, Nesheim JA, Askautrud HA, Nesbakken A, Lothe RA, Svindland A, Shepherd N, Novelli M, Johnstone E, Tomlinson I, Kerr R, Kerr DJ (2018)
    Prognostic markers for colorectal cancer: estimating ploidy and stroma
    Ann Oncol, 29 (3), 616-623
    DOI 10.1093/annonc/mdx794, PubMed 29293881
  3. Eilertsen IA, Sveen A, Strømme JM, Skotheim RI, Nesbakken A, Lothe RA (2018)
    Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer
    Int J Cancer, 144 (4), 841-847
    DOI 10.1002/ijc.31809, PubMed 30121958
  4. Engebretsen KV, Blom-Høgestøl IK, Hewitt S, Risstad H, Moum B, Kristinsson JA, Mala T (2018)
    Anemia following Roux-en-Y gastric bypass for morbid obesity; a 5-year follow-up study
    Scand J Gastroenterol, 53 (8), 917-922
    DOI 10.1080/00365521.2018.1489892, PubMed 30231804
  5. Gleditsch D, Wexels WA, Nesbakken A (2018)
    Surgical options and trends in treating rectal prolapse: long-term results in a 19-year follow-up study
    Langenbecks Arch Surg, 403 (8), 991-998
    DOI 10.1007/s00423-018-1728-4, PubMed 30415286
  6. Glomsaker T (2018)
    Necrotic gall bladder
    Tidsskr. Nor. Laegeforen., 138 (8), 748
  7. Haug HM, Johnson E, Mala T, Førland DT, Søvik TT, Johannessen HO (2018)
    Incarcerated paraesophageal hernia complicated by pancreatic damage and unusual comorbidity: Two retrospective case series
    Int J Surg Case Rep, 54, 75-78
    DOI 10.1016/j.ijscr.2018.11.064, PubMed 30529949
  8. Hauge T, Kleven OC, Johnson E, Hofstad B, Johannessen HO (2018)
    Outcome after stenting and débridement for spontaneous esophageal rupture
    Scand J Gastroenterol, 53 (4), 398-402
    DOI 10.1080/00365521.2018.1448886, PubMed 29523026
  9. Hauge T, Kleven OC, Johnson E, Hofstad B, Johannessen HO (2018)
    Outcome after accidental food bolus-induced esophageal perforation
    Scand J Gastroenterol, 53 (8), 905-909
    DOI 10.1080/00365521.2018.1495760, PubMed 30231806
  10. Hewitt S, Aasheim ET, Søvik TT, Jahnsen J, Kristinsson J, Eriksen EF, Mala T (2018)
    Relationships of serum 25-hydroxyvitamin D, ionized calcium and parathyroid hormone after obesity surgery
    Clin Endocrinol (Oxf), 88 (3), 372-379
    DOI 10.1111/cen.13531, PubMed 29235126
  11. Holme Ø, Pedersen IB, Medhus AW, Aabakken L, Glomsaker T, Kvamme JM, Løberg M, Bretthauer M, Seip B, Kjellevold Ø, Jørgensen A, Furholm S, Hoff G, de Lange T (2018)
    Endoscopy assistants influence the quality of colonoscopy
    Endoscopy, 50 (9), 871-877
    DOI 10.1055/s-0044-101706, PubMed 29444529
  12. Kleppe A, Albregtsen F, Vlatkovic L, Pradhan M, Nielsen B, Hveem TS, Askautrud HA, Kristensen GB, Nesbakken A, Trovik J, Wæhre H, Tomlinson I, Shepherd NA, Novelli M, Kerr DJ, Danielsen HE (2018)
    Chromatin organisation and cancer prognosis: a pan-cancer study
    Lancet Oncol, 19 (3), 356-369
    DOI 10.1016/S1470-2045(17)30899-9, PubMed 29402700
  13. Kværner AS, Minaguchi J, Yamani NE, Henriksen C, Ræder H, Paur I, Henriksen HB, Wiedswang G, Smeland S, Blomhoff R, Collins AR, Bøhn SK (2018)
    DNA damage in blood cells in relation to chemotherapy and nutritional status in colorectal cancer patients-A pilot study
    DNA Repair (Amst), 63, 16-24
    DOI 10.1016/j.dnarep.2018.01.005, PubMed 29414050
  14. Lassen K, Nymo LS, Kørner H, Thon K, Grindstein T, Wasmuth HH, Moger T, Bjørnbeth BA, Norderval S, Eriksen MT, Viste A (2018)
    The New National Registry for Gastrointestinal Surgery in Norway: NoRGast
    Scand J Surg, 107 (3), 201-207
    DOI 10.1177/1457496918766697, PubMed 29628007
  15. Mala T, Høgestøl I (2018)
    Abdominal Pain After Roux-En-Y Gastric Bypass for Morbid Obesity
    Scand J Surg, 107 (4), 277-284
    DOI 10.1177/1457496918772360, PubMed 29739280
  16. Mala T, Johannessen HO, Førland D, Jacobsen TH, Johnson E (2018)
    [Laparascopic resection for gastric cancer at Oslo University Hospital, Ullevål 2015–18]
    Tidsskr Nor Laegeforen, 138 (18)
    DOI 10.4045/tidsskr.18.0404, PubMed 30421737
  17. Nymo LS, Norderval S, Eriksen MT, Wasmuth HH, Kørner H, Bjørnbeth BA, Moger T, Viste A, Lassen K (2018)
    Short-term outcomes after elective colon cancer surgery: an observational study from the Norwegian registry for gastrointestinal and HPB surgery, NoRGast
    Surg Endosc, 33 (9), 2821-2833
    DOI 10.1007/s00464-018-6575-4, PubMed 30413929
  18. Ommundsen N, Nesbakken A, Wyller TB, Skovlund E, Bakka AO, Jordhøy MS, Rostoft S (2018)
    Post-discharge complications in frail older patients after surgery for colorectal cancer
    Eur J Surg Oncol, 44 (10), 1542-1547
    DOI 10.1016/j.ejso.2018.06.024, PubMed 30037638
  19. Ommundsen N, Wyller TB, Nesbakken A, Bakka AO, Jordhøy MS, Skovlund E, Rostoft S (2018)
    Preoperative geriatric assessment and tailored interventions in frail older patients with colorectal cancer: a randomized controlled trial
    Colorectal Dis, 20 (1), 16-25
    DOI 10.1111/codi.13785, PubMed 28649755
  20. Ommundsen N, Wyller TB, Nesbakken A, Bakka AO, Jordhøy MS, Skovlund E, Rostoft S (2018)
    Reply to Lawday et al
    Colorectal Dis, 20 (4), 350-351
    DOI 10.1111/codi.14059, PubMed 29502337
  21. Poelemeijer YQM, Liem RSL, Våge V, Mala T, Sundbom M, Ottosson J, Nienhuijs SW (2018)
    Perioperative Outcomes of Primary Bariatric Surgery in North-Western Europe: a Pooled Multinational Registry Analysis
    Obes Surg, 28 (12), 3916-3922
    DOI 10.1007/s11695-018-3408-4, PubMed 30027332
  22. Smeby J, Sveen A, Merok MA, Danielsen SA, Eilertsen IA, Guren MG, Dienstmann R, Nesbakken A, Lothe RA (2018)
    CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer
    Ann Oncol, 29 (5), 1227-1234
    DOI 10.1093/annonc/mdy085, PubMed 29518181
  23. Svanevik M, Risstad H, Karlsen TI, Kristinsson JA, Småstuen MC, Kolotkin RL, Søvik TT, Sandbu R, Mala T, Hjelmesæth J (2018)
    Patient-Reported Outcome Measures 2 Years After Standard and Distal Gastric Bypass-a Double-Blind Randomized Controlled Trial
    Obes Surg, 28 (3), 606-614
    DOI 10.1007/s11695-017-2891-3, PubMed 28865057
  24. Vedeld HM, Nesbakken A, Lothe RA, Lind GE (2018)
    Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer
    Clin Epigenetics, 10, 70
    DOI 10.1186/s13148-018-0503-2, PubMed 29854011
  25. Werling M, Fändriks L, Olbers T, Mala T, Kristinsson J, Stenlöf K, Wallenius V, Docherty NG, le Roux CW (2018)
    Biliopancreatic Diversion is associated with greater increases in energy expenditure than Roux-en-Y Gastric Bypass
    PLoS One, 13 (4), e0194538
    DOI 10.1371/journal.pone.0194538, PubMed 29617391

Publications 2017

  1. Amdal CD, Jacobsen AB, Falk RS, Johnson E, Os SS, Warloe T, Bjordal K (2017)
    Improved treatment decisions in patients with esophageal cancer
    Acta Oncol, 56 (10), 1286-1294
    DOI 10.1080/0284186X.2017.1346379, PubMed 28686501
  2. Chellappa S, Hugenschmidt H, Hagness M, Subramani S, Melum E, Line PD, Labori KJ, Wiedswang G, Taskén K, Aandahl EM (2017)
    CD8+ T Cells That Coexpress RORγt and T-bet Are Functionally Impaired and Expand in Patients with Distal Bile Duct Cancer
    J Immunol, 198 (4), 1729-1739
    DOI 10.4049/jimmunol.1600061, PubMed 28053236
  3. Dienstmann R, Mason MJ, Sinicrope FA, Phipps AI, Tejpar S, Nesbakken A, Danielsen SA, Sveen A, Buchanan DD, Clendenning M, Rosty C, Bot B, Alberts SR, Milburn Jessup J, Lothe RA, Delorenzi M, Newcomb PA, Sargent D, Guinney J (2017)
    Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study
    Ann Oncol, 28 (5), 1023-1031
    DOI 10.1093/annonc/mdx052, PubMed 28453697
  4. Farnes I, Johnson E, Johannessen HO (2017)
    Management of gastric conduit retention following hybrid and minimally invasive esophagectomy for esophageal cancer: Two retrospective case series
    Int J Surg Case Rep, 41, 505-510
    DOI 10.1016/j.ijscr.2017.11.040, PubMed 29546028
  5. Henriksen HB, Ræder H, Bøhn SK, Paur I, Kværner AS, Billington SÅ, Eriksen MT, Wiedsvang G, Erlund I, Færden A, Veierød MB, Zucknick M, Smeland S, Blomhoff R (2017)
    The Norwegian dietary guidelines and colorectal cancer survival (CRC-NORDIET) study: a food-based multicentre randomized controlled trial
    BMC Cancer, 17 (1), 83
    DOI 10.1186/s12885-017-3072-4, PubMed 28137255
  6. Høgestøl IK, Chahal-Kummen M, Eribe I, Brunborg C, Stubhaug A, Hewitt S, Kristinsson J, Mala T (2017)
    Chronic Abdominal Pain and Symptoms 5 Years After Gastric Bypass for Morbid Obesity
    Obes Surg, 27 (6), 1438-1445
    DOI 10.1007/s11695-016-2499-z, PubMed 28028658
  7. Kvalem IL, Bergh I, Sogg S, Mala T (2017)
    Psychosocial characteristics associated with symptom perception 1 year after gastric bypass surgery-a prospective study
    Surg Obes Relat Dis, 13 (11), 1908-1913
    DOI 10.1016/j.soard.2017.06.008, PubMed 28760328
  8. Labori KJ, Guren MG, Brudvik KW, Røsok BI, Waage A, Nesbakken A, Larsen S, Dueland S, Edwin B, Bjørnbeth BA (2017)
    Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival
    Colorectal Dis, 19 (8), 731-738
    DOI 10.1111/codi.13622, PubMed 28181384
  9. Mala T, Kristinsson J (2017)
    Gastrointestinal symptoms after bariatric surgery-more focus needed
    Surg Obes Relat Dis, 13 (7), 1251
    DOI 10.1016/j.soard.2017.03.009, PubMed 28438495
  10. Risstad H, Kristinsson JA, Fagerland MW, le Roux CW, Birkeland KI, Gulseth HL, Thorsby PM, Vincent RP, Engström M, Olbers T, Mala T (2017)
    Bile acid profiles over 5 years after gastric bypass and duodenal switch: results from a randomized clinical trial
    Surg Obes Relat Dis, 13 (9), 1544-1553
    DOI 10.1016/j.soard.2017.05.024, PubMed 28756050
  11. Seeberg LT, Brunborg C, Waage A, Hugenschmidt H, Renolen A, Stav I, Bjørnbeth BA, Borgen E, Naume B, Brudvik KW, Wiedswang G (2017)
    Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases
    Ann Surg Oncol, 24 (8), 2113-2121
    DOI 10.1245/s10434-017-5818-2, PubMed 28258416
  12. Skyrud KD, Myklebust TÅ, Bray F, Eriksen MT, de Lange T, Larsen IK, Møller B (2017)
    How Many Deaths from Colorectal Cancer Can Be Prevented by 2030? A Scenario-Based Quantification of Risk Factor Modification, Screening, and Treatment in Norway
    Cancer Epidemiol Biomarkers Prev, 26 (9), 1420-1426
    DOI 10.1158/1055-9965.EPI-17-0265, PubMed 28626069
  13. Sveen A, Bruun J, Eide PW, Eilertsen IA, Ramirez L, Murumägi A, Arjama M, Danielsen SA, Kryeziu K, Elez E, Tabernero J, Guinney J, Palmer HG, Nesbakken A, Kallioniemi O, Dienstmann R, Lothe RA (2017)
    Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies
    Clin Cancer Res, 24 (4), 794-806
    DOI 10.1158/1078-0432.CCR-17-1234, PubMed 29242316
  14. Sveen A, Johannessen B, Tengs T, Danielsen SA, Eilertsen IA, Lind GE, Berg KCG, Leithe E, Meza-Zepeda LA, Domingo E, Myklebost O, Kerr D, Tomlinson I, Nesbakken A, Skotheim RI, Lothe RA (2017)
    Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1
    Genome Med, 9 (1), 46
    DOI 10.1186/s13073-017-0434-0, PubMed 28539123
  15. Vedeld HM, Merok M, Jeanmougin M, Danielsen SA, Honne H, Presthus GK, Svindland A, Sjo OH, Hektoen M, Eknaes M, Nesbakken A, Lothe RA, Lind GE (2017)
    CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers
    Int J Cancer, 141 (5), 967-976
    DOI 10.1002/ijc.30796, PubMed 28542846
  16. Åsli LM, Johannesen TB, Myklebust TÅ, Møller B, Eriksen MT, Guren MG (2017)
    Preoperative chemoradiotherapy for rectal cancer and impact on outcomes - A population-based study
    Radiother Oncol, 123 (3), 446-453
    DOI 10.1016/j.radonc.2017.04.012, PubMed 28483302

Publications 2016

  1. Boye K, Jacob H, Frikstad KA, Nesland JM, Maelandsmo GM, Dahl O, Nesbakken A, Flatmark K (2016)
    Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy
    Cancer Med, 5 (8), 1840-9
    DOI 10.1002/cam4.766, PubMed 27273130
  2. Domingo E, Freeman-Mills L, Rayner E, Glaire M, Briggs S, Vermeulen L, Fessler E, Medema JP, Boot A, Morreau H, van Wezel T, Liefers GJ, Lothe RA, Danielsen SA, Sveen A, Nesbakken A, Zlobec I, Lugli A, Koelzer VH, Berger MD, Castellví-Bel S, Muñoz J, Epicolon consortium, de Bruyn M, Nijman HW et al. (2016)
    Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study
    Lancet Gastroenterol Hepatol, 1 (3), 207-216
    DOI 10.1016/S2468-1253(16)30014-0, PubMed 28404093
  3. Gleditsch D, Søreide OK, Nesbakken A (2016)
    Managing Malignant Colorectal Obstruction with Self-Expanding Stents. A Closer Look at Bowel Perforations and Failed Procedures
    J Gastrointest Surg, 20 (9), 1643-9
    DOI 10.1007/s11605-016-3186-z, PubMed 27342437
  4. Grøtting MS, Løberg EM, Johannessen HO, Johnson E (2016)
    Resection for oesophageal cancer - complications and survival
    Tidsskr Nor Laegeforen, 136 (9), 809-13
    DOI 10.4045/tidsskr.15.1136, PubMed 27221180
  5. Mala T (2016)
    The Gastric Remnant in Roux-en-Y Gastric Bypass: Challenges and Possibilities
    J Clin Gastroenterol, 50 (7), 527-31
    DOI 10.1097/MCG.0000000000000550, PubMed 27203428
  6. Risstad H, Svanevik M, Kristinsson JA, Hjelmesæth J, Aasheim ET, Hofsø D, Søvik TT, Karlsen TI, Fagerland MW, Sandbu R, Mala T (2016)
    Standard vs Distal Roux-en-Y Gastric Bypass in Patients With Body Mass Index 50 to 60: A Double-blind, Randomized Clinical Trial
    JAMA Surg, 151 (12), 1146-1155
    DOI 10.1001/jamasurg.2016.2798, PubMed 27626242
  7. Rønning B, Wyller TB, Nesbakken A, Skovlund E, Jordhøy MS, Bakka A, Rostoft S (2016)
    Quality of life in older and frail patients after surgery for colorectal cancer-A follow-up study
    J Geriatr Oncol, 7 (3), 195-200
    DOI 10.1016/j.jgo.2016.03.002, PubMed 27067579
  8. Skyrud KD, Bray F, Eriksen MT, Nilssen Y, Møller B (2016)
    Regional variations in cancer survival: Impact of tumour stage, socioeconomic status, comorbidity and type of treatment in Norway
    Int J Cancer, 138 (9), 2190-200
    DOI 10.1002/ijc.29967, PubMed 26679150
  9. Stormark K, Søreide K, Søreide JA, Kvaløy JT, Pfeffer F, Eriksen MT, Nedrebø BS, Kørner H (2016)
    Nationwide implementation of laparoscopic surgery for colon cancer: short-term outcomes and long-term survival in a population-based cohort
    Surg Endosc, 30 (11), 4853-4864
    DOI 10.1007/s00464-016-4819-8, PubMed 26905577
  10. Stornes T, Wibe A, Nesbakken A, Myklebust TÅ, Endreseth BH (2016)
    National Early Rectal Cancer Treatment Revisited
    Dis Colon Rectum, 59 (7), 623-9
    DOI 10.1097/DCR.0000000000000591, PubMed 27270514
  11. Therkelsen SP, Hetland G, Lyberg T, Lygren I, Johnson E (2016)
    Effect of a Medicinal Agaricus blazei Murill-Based Mushroom Extract, AndoSan™, on Symptoms, Fatigue and Quality of Life in Patients with Ulcerative Colitis in a Randomized Single-Blinded Placebo Controlled Study
    PLoS One, 11 (3), e0150191
    DOI 10.1371/journal.pone.0150191, PubMed 26933886
  12. Therkelsen SP, Hetland G, Lyberg T, Lygren I, Johnson E (2016)
    Effect of the Medicinal Agaricus blazei Murill-Based Mushroom Extract, AndoSanTM, on Symptoms, Fatigue and Quality of Life in Patients with Crohn's Disease in a Randomized Single-Blinded Placebo Controlled Study
    PLoS One, 11 (7), e0159288
    DOI 10.1371/journal.pone.0159288, PubMed 27415795

Publications 2015

  1. Brudvik KW, Seeberg LT, Hugenschmidt H, Renolen A, Schirmer CB, Brunborg C, Bjørnbeth BA, Borgen E, Naume B, Waage A, Wiedswang G (2015)
    Detection of Circulating Tumor Cells at Surgery and at Follow-Up Assessment to Predict Survival After Two-Stage Liver Resection of Colorectal Liver Metastases
    Ann Surg Oncol, 22 (12), 4029-37
    DOI 10.1245/s10434-015-4482-7, PubMed 25801354
  2. Bruun J, Kolberg M, Ahlquist TC, Røyrvik EC, Nome T, Leithe E, Lind GE, Merok MA, Rognum TO, Bjørkøy G, Johansen T, Lindblom A, Sun XF, Svindland A, Liestøl K, Nesbakken A, Skotheim RI, Lothe RA (2015)
    Regulator of Chromosome Condensation 2 Identifies High-Risk Patients within Both Major Phenotypes of Colorectal Cancer
    Clin Cancer Res, 21 (16), 3759-70
    DOI 10.1158/1078-0432.CCR-14-3294, PubMed 25910952
  3. Chellappa S, Hugenschmidt H, Hagness M, Line PD, Labori KJ, Wiedswang G, Taskén K, Aandahl EM (2015)
    Regulatory T cells that co-express RORγt and FOXP3 are pro-inflammatory and immunosuppressive and expand in human pancreatic cancer
    Oncoimmunology, 5 (4), e1102828
    DOI 10.1080/2162402X.2015.1102828, PubMed 27141387
  4. Guren MG, Kørner H, Pfeffer F, Myklebust TÅ, Eriksen MT, Edna TH, Larsen SG, Knudsen KO, Nesbakken A, Wasmuth HH, Vonen B, Hofsli E, Færden AE, Brændengen M, Dahl O, Steigen SE, Johansen MJ, Lindsetmo RO, Drolsum A, Tollåli G, Dørum LM, Møller B, Wibe A (2015)
    Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993-2010
    Acta Oncol, 54 (10), 1714-22
    DOI 10.3109/0284186X.2015.1034876, PubMed 25924970
  5. Mala T (2015)
    The ASMBS textbook of bariatric surgery
    Tidsskr. Nor. Laegeforen., 135 (9), 875
    DOI 10.4045/tidsskr.15.0201
  6. Mala T, Hewitt S, Høgestøl IK, Kjellevold K, Kristinsson JA, Risstad H (2015)
    [Dumping syndrome following gastric surgery]
    Tidsskr Nor Laegeforen, 135 (2), 137-41
    DOI 10.4045/tidsskr.14.0550, PubMed 25625992
  7. Mala T, Hewitt S, Høgestøl IK, Kjellevold K, Kristinsson JA, Risstad H (2015)
    [Dumping syndrome following gastric surgery]
    Tidsskr Nor Laegeforen, 135 (4), 310
    DOI 10.4045/tidsskr.15.0163, PubMed 25707648
  8. Risstad H, Søvik TT, Engström M, Aasheim ET, Fagerland MW, Olsén MF, Kristinsson JA, le Roux CW, Bøhmer T, Birkeland KI, Mala T, Olbers T (2015)
    Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60: a randomized clinical trial
    JAMA Surg, 150 (4), 352-61
    DOI 10.1001/jamasurg.2014.3579, PubMed 25650964
  9. Seeberg LT, Waage A, Brunborg C, Hugenschmidt H, Renolen A, Stav I, Bjørnbeth BA, Brudvik KW, Borgen EF, Naume B, Wiedswang G (2015)
    Circulating tumor cells in patients with colorectal liver metastasis predict impaired survival
    Ann Surg, 261 (1), 164-71
    DOI 10.1097/SLA.0000000000000580, PubMed 24509211
  10. Svanevik M, Risstad H, Hofsø D, Schou CF, Solheim B, Søvik TT, Kristinsson J, Hjelmesæth J, Mala T, Sandbu R (2015)
    Perioperative Outcomes of Proximal and Distal Gastric Bypass in Patients with BMI Ranged 50-60 kg/m(2)--A Double-Blind, Randomized Controlled Trial
    Obes Surg, 25 (10), 1788-95
    DOI 10.1007/s11695-015-1621-y, PubMed 25761943
  11. Aarås AM, Reitan-Gjersøe TA, Waage A, Mala T, Edwin B, Løberg EM, Abildgaard A, Røsok BI (2015)
    Laparoscopic resection of recurrent ectopic hepatocellular carcinoma: A case report with review of the literature and guidelines for follow-up
    Int J Surg Case Rep, 17, 92-5
    DOI 10.1016/j.ijscr.2015.10.014, PubMed 26590353

Publications 2014

  1. Bruun J, Kolberg M, Nesland JM, Svindland A, Nesbakken A, Lothe RA (2014)
    Prognostic Significance of β-Catenin, E-Cadherin, and SOX9 in Colorectal Cancer: Results from a Large Population-Representative Series
    Front Oncol, 4, 118
    DOI 10.3389/fonc.2014.00118, PubMed 24904831
  2. Danielsen SA, Eide PW, Nesbakken A, Guren T, Leithe E, Lothe RA (2014)
    Portrait of the PI3K/AKT pathway in colorectal cancer
    Biochim Biophys Acta, 1855 (1), 104-21
    DOI 10.1016/j.bbcan.2014.09.008, PubMed 25450577
  3. Hauge T, Johnson E, Sandstad O, Johannessen HO, Trondsen E (2014)
    Surgical treatment of epiphrenic oesophageal diverticulum
    Tidsskr Nor Laegeforen, 134 (10), 1047-50
    DOI 10.4045/tidsskr.13.1336, PubMed 24865729
  4. Hewitt S, Humerfelt S, Søvik TT, Aasheim ET, Risstad H, Kristinsson J, Mala T (2014)
    Long-term improvements in pulmonary function 5 years after bariatric surgery
    Obes Surg, 24 (5), 705-11
    DOI 10.1007/s11695-013-1159-9, PubMed 24435516
  5. Hveem TS, Merok MA, Pretorius ME, Novelli M, Bævre MS, Sjo OH, Clinch N, Liestøl K, Svindland A, Lothe RA, Nesbakken A, Danielsen HE (2014)
    Prognostic impact of genomic instability in colorectal cancer
    Br J Cancer, 110 (8), 2159-64
    DOI 10.1038/bjc.2014.133, PubMed 24642618
  6. Ingebrigtsen VA, Boye K, Nesland JM, Nesbakken A, Flatmark K, Fodstad Ø (2014)
    B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome
    BMC Cancer, 14, 602
    DOI 10.1186/1471-2407-14-602, PubMed 25139714
  7. Joranger P, Nesbakken A, Hoff G, Sorbye H, Oshaug A, Aas E (2014)
    Modeling and validating the cost and clinical pathway of colorectal cancer
    Med Decis Making, 35 (2), 255-65
    DOI 10.1177/0272989X14544749, PubMed 25073464
  8. Løvf M, Nome T, Bruun J, Eknaes M, Bakken AC, Mpindi JP, Kilpinen S, Rognum TO, Nesbakken A, Kallioniemi O, Lothe RA, Skotheim RI (2014)
    A novel transcript, VNN1-AB, as a biomarker for colorectal cancer
    Int J Cancer, 135 (9), 2077-84
    DOI 10.1002/ijc.28855, PubMed 24687856
  9. Mala T (2014)
    Postprandial hyperinsulinemic hypoglycemia after gastric bypass surgical treatment
    Surg Obes Relat Dis, 10 (6), 1220-5
    DOI 10.1016/j.soard.2014.01.010, PubMed 25002326
  10. Mala T, Harsem NK, Røstad S, Mathisen LC, Jacobsen AF (2014)
    Perforation of the Pregnant Uterus during Laparoscopy for Suspected Internal Herniation after Gastric Bypass
    Case Rep Obstet Gynecol, 2014, 720181
    DOI 10.1155/2014/720181, PubMed 25548693
  11. Naume B, Synnestvedt M, Falk RS, Wiedswang G, Weyde K, Risberg T, Kersten C, Mjaaland I, Vindi L, Sommer HH, Sætersdal AB, Rypdal MC, Bendigtsen Schirmer C, Wist EA, Borgen E (2014)
    Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer
    J Clin Oncol, 32 (34), 3848-57
    DOI 10.1200/JCO.2014.56.9327, PubMed 25366688
  12. Nome T, Hoff AM, Bakken AC, Rognum TO, Nesbakken A, Skotheim RI (2014)
    High frequency of fusion transcripts involving TCF7L2 in colorectal cancer: novel fusion partner and splice variants
    PLoS One, 9 (3), e91264
    DOI 10.1371/journal.pone.0091264, PubMed 24608966
  13. Ommundsen N, Wyller TB, Nesbakken A, Jordhøy MS, Bakka A, Skovlund E, Rostoft S (2014)
    Frailty is an independent predictor of survival in older patients with colorectal cancer
    Oncologist, 19 (12), 1268-75
    DOI 10.1634/theoncologist.2014-0237, PubMed 25355846
  14. Søndenaa K, Quirke P, Hohenberger W, Sugihara K, Kobayashi H, Kessler H, Brown G, Tudyka V, D'Hoore A, Kennedy RH, West NP, Kim SH, Heald R, Storli KE, Nesbakken A, Moran B (2014)
    The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery : proceedings of a consensus conference
    Int J Colorectal Dis, 29 (4), 419-28
    DOI 10.1007/s00384-013-1818-2, PubMed 24477788
  15. Vedeld HM, Andresen K, Eilertsen IA, Nesbakken A, Seruca R, Gladhaug IP, Thiis-Evensen E, Rognum TO, Boberg KM, Lind GE (2014)
    The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers
    Int J Cancer, 136 (4), 844-53
    DOI 10.1002/ijc.29039, PubMed 24948044
  16. Vogel LK, Sæbø M, Høyer H, Kopp TI, Vogel U, Godiksen S, Frenzel FB, Hamfjord J, Bowitz-Lothe IM, Johnson E, Kure EH, Andersen V (2014)
    Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesis
    PLoS One, 9 (8), e105254
    DOI 10.1371/journal.pone.0105254, PubMed 25166592

Publications 2013

  1. Aftab H, Risstad H, Søvik TT, Bernklev T, Hewitt S, Kristinsson JA, Mala T (2013)
    Five-year outcome after gastric bypass for morbid obesity in a Norwegian cohort
    Surg Obes Relat Dis, 10 (1), 71-8
    DOI 10.1016/j.soard.2013.05.003, PubMed 24182445
  2. Hewitt S, Søvik TT, Aasheim ET, Kristinsson J, Jahnsen J, Birketvedt GS, Bøhmer T, Eriksen EF, Mala T (2013)
    Secondary hyperparathyroidism, vitamin D sufficiency, and serum calcium 5 years after gastric bypass and duodenal switch
    Obes Surg, 23 (3), 384-90
    DOI 10.1007/s11695-012-0772-3, PubMed 23015268
  3. Holme Ø, Moritz V, Bretthauer M, Seip B, Glomsaker T, de Lange T, Aabakken L, Stallemo A, Høie O, Dahler S, Sandvei PK, Stray N, Ystrøm CM, Hoff G (2013)
    [Pain in connection with colonoscopy in Norway]
    Tidsskr Nor Laegeforen, 133 (10), 1074-8
    DOI 10.4045/tidsskr.12.1467, PubMed 23712171
  4. Mala T, Kristinsson J (2013)
    [Acute internal hernia following gastric bypass for morbid obesity]
    Tidsskr Nor Laegeforen, 133 (6), 640-4
    DOI 10.4045/tidsskr.12.1113, PubMed 23552158
  5. Miras AD, Risstad H, Baqai N, Law S, Søvik TT, Mala T, Olbers T, Kristinsson JA, le Roux CW (2013)
    Application of the International Diabetes Federation and American Diabetes Association criteria in the assessment of metabolic control after bariatric surgery
    Diabetes Obes Metab, 16 (1), 86-9
    DOI 10.1111/dom.12177, PubMed 23841525
  6. Nedrebø BS, Søreide K, Nesbakken A, Eriksen MT, Søreide JA, Kørner H, Norwegian Colorectal Cancer Group (2013)
    Risk factors associated with poor lymph node harvest after colon cancer surgery in a national cohort
    Colorectal Dis, 15 (6), e301-8
    DOI 10.1111/codi.12245, PubMed 23582027
  7. Nome T, Thomassen GO, Bruun J, Ahlquist T, Bakken AC, Hoff AM, Rognum T, Nesbakken A, Lorenz S, Sun J, Barros-Silva JD, Lind GE, Myklebost O, Teixeira MR, Meza-Zepeda LA, Lothe RA, Skotheim RI (2013)
    Common fusion transcripts identified in colorectal cancer cell lines by high-throughput RNA sequencing
    Transl Oncol, 6 (5), 546-53
    DOI 10.1593/tlo.13457, PubMed 24151535
  8. Rønning B, Wyller TB, Jordhøy MS, Nesbakken A, Bakka A, Seljeflot I, Kristjansson SR (2013)
    Frailty indicators and functional status in older patients after colorectal cancer surgery
    J Geriatr Oncol, 5 (1), 26-32
    DOI 10.1016/j.jgo.2013.08.001, PubMed 24484715
  9. Sveen A, Nesbakken A, Ågesen TH, Guren MG, Tveit KM, Skotheim RI, Lothe RA (2013)
    Anticipating the clinical use of prognostic gene expression-based tests for colon cancer stage II and III: is Godot finally arriving?
    Clin Cancer Res, 19 (24), 6669-77
    DOI 10.1158/1078-0432.CCR-13-1769, PubMed 24166914

Publications 2012

  1. Agesen TH, Sveen A, Merok MA, Lind GE, Nesbakken A, Skotheim RI, Lothe RA (2012)
    ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis
    Gut, 61 (11), 1560-7
    DOI 10.1136/gutjnl-2011-301179, PubMed 22213796
  2. Ahmed D, Danielsen SA, Aagesen TH, Bretthauer M, Thiis-Evensen E, Hoff G, Rognum TO, Nesbakken A, Lothe RA, Lind GE (2012)
    A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumors
    Clin Transl Gastroenterol, 3 (12), e27
    DOI 10.1038/ctg.2012.21, PubMed 23324654
  3. Cekaite L, Rantala JK, Bruun J, Guriby M, Agesen TH, Danielsen SA, Lind GE, Nesbakken A, Kallioniemi O, Lothe RA, Skotheim RI (2012)
    MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer
    Neoplasia, 14 (9), 868-79
    DOI 10.1593/neo.121094, PubMed 23019418
  4. Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Holm R, Giercksky KE, Nesland JM (2012)
    Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness
    Histopathology, 61 (3), 350-64
    DOI 10.1111/j.1365-2559.2012.04223.x, PubMed 22690749
  5. Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Holm R, Giercksky KE, Nesland JM (2012)
    Expression of cyclooxygenase-2 in invasive breast carcinomas and its prognostic impact
    Histol Histopathol, 27 (10), 1315-25
    DOI 10.14670/HH-27.1315, PubMed 22936450
  6. Johnson E, Førland DT, Hetland G, Sætre L, Olstad OK, Lyberg T (2012)
    Effect of AndoSan™ on expression of adhesion molecules and production of reactive oxygen species in human monocytes and granulocytes in vivo
    Scand J Gastroenterol, 47 (8-9), 984-92
    DOI 10.3109/00365521.2012.660544, PubMed 22564240
  7. Johnson E, Kjellevold K, Johannessen HO, Drolsum A (2012)
    Long-term outcome after resection rectopexy for internal rectal intussusception
    ISRN Gastroenterol, 2012, 824671
    DOI 10.5402/2012/824671, PubMed 23346411
  8. Kristjansson SR, Ronning B, Hurria A, Skovlund E, Jordhoy MS, Nesbakken A, Wyller TB (2012)
    A comparison of two pre-operative frailty measures in older surgical cancer patients
    J. Geriatr. Oncol., 3 (1), 1-7
    DOI 10.1016/j.jgo.2011.09.002
  9. Larssen L, Medhus AW, Körner H, Glomsaker T, Søberg T, Gleditsch D, Hovde Ø, Tholfsen JK, Skreden K, Nesbakken A, Hauge T (2012)
    Long-term outcome of palliative treatment with self-expanding metal stents for malignant obstructions of the GI tract
    Scand J Gastroenterol, 47 (12), 1505-14
    DOI 10.3109/00365521.2012.711854, PubMed 23046494
  10. Mala T, Søvik TT, Schou CF, Kristinsson J (2012)
    Blood clot obstruction of the jejunojejunostomy after laparoscopic gastric bypass
    Surg Obes Relat Dis, 9 (2), 234-7
    DOI 10.1016/j.soard.2011.12.014, PubMed 22421098
  11. Merok MA, Ahlquist T, Røyrvik EC, Tufteland KF, Hektoen M, Sjo OH, Mala T, Svindland A, Lothe RA, Nesbakken A (2012)
    Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series
    Ann Oncol, 24 (5), 1274-82
    DOI 10.1093/annonc/mds614, PubMed 23235802
  12. Sjo OH, Merok MA, Svindland A, Nesbakken A (2012)
    Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer
    Dis Colon Rectum, 55 (3), 307-15
    DOI 10.1097/DCR.0b013e3182423f62, PubMed 22469798
  13. Sveen A, Bakken AC, Ågesen TH, Lind GE, Nesbakken A, Nordgård O, Brackmann S, Rognum TO, Lothe RA, Skotheim RI (2012)
    The exon-level biomarker SLC39A14 has organ-confined cancer-specificity in colorectal cancer
    Int J Cancer, 131 (6), 1479-85
    DOI 10.1002/ijc.27399, PubMed 22173985
  14. Sveen A, Ågesen TH, Nesbakken A, Meling GI, Rognum TO, Liestøl K, Skotheim RI, Lothe RA (2012)
    ColoGuidePro: a prognostic 7-gene expression signature for stage III colorectal cancer patients
    Clin Cancer Res, 18 (21), 6001-10
    DOI 10.1158/1078-0432.CCR-11-3302, PubMed 22991413
  15. Synnestvedt M, Borgen E, Wist E, Wiedswang G, Weyde K, Risberg T, Kersten C, Mjaaland I, Vindi L, Schirmer C, Nesland JM, Naume B (2012)
    Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study
    BMC Cancer, 12, 616
    DOI 10.1186/1471-2407-12-616, PubMed 23259667
  16. Søvik TT, Karlsson J, Aasheim ET, Fagerland MW, Björkman S, Engström M, Kristinsson J, Olbers T, Mala T (2012)
    Gastrointestinal function and eating behavior after gastric bypass and duodenal switch
    Surg Obes Relat Dis, 9 (5), 641-7
    DOI 10.1016/j.soard.2012.06.006, PubMed 22951078

Publications 2011

  1. Andersson T, Lunde OC, Johnson E, Moum T, Nesbakken A (2011)
    Long-term functional outcome and quality of life after restorative proctocolectomy with ileo-anal anastomosis for colitis
    Colorectal Dis, 13 (4), 431-7
    DOI 10.1111/j.1463-1318.2009.02163.x, PubMed 20002693
  2. Bornholdt J, Friis S, Godiksen S, Poulsen SS, Santoni-Rugiu E, Bisgaard HC, Lothe IM, Ikdahl T, Tveit KM, Johnson E, Kure EH, Vogel LK (2011)
    The level of claudin-7 is reduced as an early event in colorectal carcinogenesis
    BMC Cancer, 11, 65
    DOI 10.1186/1471-2407-11-65, PubMed 21310043
  3. Danielsen SA, Cekaite L, Ågesen TH, Sveen A, Nesbakken A, Thiis-Evensen E, Skotheim RI, Lind GE, Lothe RA (2011)
    Phospholipase C isozymes are deregulated in colorectal cancer--insights gained from gene set enrichment analysis of the transcriptome
    PLoS One, 6 (9), e24419
    DOI 10.1371/journal.pone.0024419, PubMed 21909432
  4. Flatmark K, Borgen E, Nesland JM, Rasmussen H, Johannessen HO, Bukholm I, Rosales R, Hårklau L, Jacobsen HJ, Sandstad B, Boye K, Fodstad Ø (2011)
    Disseminated tumour cells as a prognostic biomarker in colorectal cancer
    Br J Cancer, 104 (9), 1434-9
    DOI 10.1038/bjc.2011.97, PubMed 21448171
  5. Hetland G, Johnson E, Lyberg T, Kvalheim G (2011)
    The Mushroom Agaricus blazei Murill Elicits Medicinal Effects on Tumor, Infection, Allergy, and Inflammation through Its Modulation of Innate Immunity and Amelioration of Th1/Th2 Imbalance and Inflammation
    Adv Pharmacol Sci, 2011, 157015
    DOI 10.1155/2011/157015, PubMed 21912538
  6. Hølmebakk T, Solbakken A, Mala T, Nesbakken A (2011)
    Clinical prediction of survival by surgeons for patients with incurable abdominal malignancy
    Eur J Surg Oncol, 37 (7), 571-5
    DOI 10.1016/j.ejso.2011.02.009, PubMed 21444178
  7. Janni W, Vogl FD, Wiedswang G, Synnestvedt M, Fehm T, Jückstock J, Borgen E, Rack B, Braun S, Sommer H, Solomayer E, Pantel K, Nesland J, Friese K, Naume B (2011)
    Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse--a European pooled analysis
    Clin Cancer Res, 17 (9), 2967-76
    DOI 10.1158/1078-0432.CCR-10-2515, PubMed 21415211
  8. Larssen L, Medhus AW, Hjermstad MJ, Körner H, Glomsaker T, Søberg T, Gleditsch D, Hovde O, Nesbakken A, Tholfsen JK, Skreden K, Hauge T (2011)
    Patient-reported outcomes in palliative gastrointestinal stenting: a Norwegian multicenter study
    Surg Endosc, 25 (10), 3162-9
    DOI 10.1007/s00464-011-1680-7, PubMed 21487867
  9. Lind GE, Danielsen SA, Ahlquist T, Merok MA, Andresen K, Skotheim RI, Hektoen M, Rognum TO, Meling GI, Hoff G, Bretthauer M, Thiis-Evensen E, Nesbakken A, Lothe RA (2011)
    Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas
    Mol Cancer, 10, 85
    DOI 10.1186/1476-4598-10-85, PubMed 21777459
  10. Lind GE, Raiborg C, Danielsen SA, Rognum TO, Thiis-Evensen E, Hoff G, Nesbakken A, Stenmark H, Lothe RA (2011)
    SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis
    Oncogene, 30 (37), 3967-78
    DOI 10.1038/onc.2011.109, PubMed 21499309
  11. Mala T (2011)
    Self-expanding metallic stents as bridge to surgery in obstructing colorectal cancer (Br J Surg 2011; 98: 275-281) Commentary
    Br. J. Surg., 98 (2), 281
    DOI 10.1002/bjs.7337
  12. Nedrebø BS, Søreide K, Eriksen MT, Dørum LM, Kvaløy JT, Søreide JA, Kørner H, Norwegian Colorectal Cancer Registry (2011)
    Survival effect of implementing national treatment strategies for curatively resected colonic and rectal cancer
    Br J Surg, 98 (5), 716-23
    DOI 10.1002/bjs.7426, PubMed 21341253
  13. Nesbakken A, Kristinsson J, Svindland A, Lunde OC (2011)
    Endoscopic snare resection followed by laser ablation in the treatment of large, sessile rectal adenomas
    Scand J Surg, 100 (2), 99-104
    DOI 10.1177/145749691110000206, PubMed 21737385
  14. Schou CF, Søvik TT, Aasheim ET, Kristinsson J, Mala T (2011)
    [Treating morbid obesity with laparoscopic biliopancreatic diversion with duodenal switch]
    Tidsskr Nor Laegeforen, 131 (19), 1882-6
    DOI 10.4045/tidsskr.10.1164, PubMed 21984293
  15. Sirnes S, Bruun J, Kolberg M, Kjenseth A, Lind GE, Svindland A, Brech A, Nesbakken A, Lothe RA, Leithe E, Rivedal E (2011)
    Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome
    Int J Cancer, 131 (3), 570-81
    DOI 10.1002/ijc.26392, PubMed 21866551
  16. Sjo OH, Berg M, Merok MA, Kolberg M, Svindland A, Lothe RA, Nesbakken A (2011)
    Peritoneal carcinomatosis of colon cancer origin: highest incidence in women and in patients with right-sided tumors
    J Surg Oncol, 104 (7), 792-7
    DOI 10.1002/jso.21959, PubMed 21547915
  17. Sveen A, Agesen TH, Nesbakken A, Rognum TO, Lothe RA, Skotheim RI (2011)
    Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival
    Genome Med, 3 (5), 32
    DOI 10.1186/gm248, PubMed 21619627
  18. Søvik TT, Aasheim ET, Taha O, Engström M, Fagerland MW, Björkman S, Kristinsson J, Birkeland KI, Mala T, Olbers T (2011)
    Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial
    Ann Intern Med, 155 (5), 281-91
    DOI 10.7326/0003-4819-155-5-201109060-00005, PubMed 21893621
  19. Wik TA, Hjorthaug JO, Johannessen HO, Johnson E (2011)
    Sigmoidostomy-related parastomal hernia
    Scand J Surg, 100 (3), 186-9
    DOI 10.1177/145749691110000309, PubMed 22108747
  20. Ågesen TH, Berg M, Clancy T, Thiis-Evensen E, Cekaite L, Lind GE, Nesland JM, Bakka A, Mala T, Hauss HJ, Fetveit T, Vatn MH, Hovig E, Nesbakken A, Lothe RA, Skotheim RI (2011)
    CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancer
    Genes Immun, 12 (8), 653-62
    DOI 10.1038/gene.2011.43, PubMed 21716316
  21. Aasheim ET, Elshorbagy AK, Diep LM, Søvik TT, Mala T, Valdivia-Garcia M, Olbers T, Bøhmer T, Birkeland KI, Refsum H (2011)
    Effect of bariatric surgery on sulphur amino acids and glutamate
    Br J Nutr, 106 (3), 432-40
    DOI 10.1017/S0007114511000201, PubMed 21554803

Publications 2010

  1. Berg M, Agesen TH, Thiis-Evensen E, INFAC-study group, Merok MA, Teixeira MR, Vatn MH, Nesbakken A, Skotheim RI, Lothe RA (2010)
    Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci
    Mol Cancer, 9, 100
    DOI 10.1186/1476-4598-9-100, PubMed 20459617
  2. Gondal G, Johnson E, Paulsen V, Hasan B (2010)
    [Treatment of neutropenic enterocolitis]
    Tidsskr Nor Laegeforen, 130 (2), 143-5
    DOI 10.4045/tidsskr.08.0089, PubMed 20125203
  3. Knævelsrud H, Ahlquist T, Merok MA, Nesbakken A, Stenmark H, Lothe RA, Simonsen A (2010)
    UVRAG mutations associated with microsatellite unstable colon cancer do not affect autophagy
    Autophagy, 6 (7), 863-70
    DOI 10.4161/auto.6.7.13033, PubMed 20724836
  4. Kristjansson SR, Jordhoy MS, Nesbakken A, Skovlund E, Bakka A, Johannessen HO, Wyller TB (2010)
    Which elements of a comprehensive geriatric assessment (CGA) predict post-operative complications and early mortality after colorectal cancer surgery?
    J. Geriatr. Oncol., 1 (2), 57-65
    DOI 10.1016/j.jgo.2010.06.001
  5. Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, Lingjaerde OC, Stromberg M, Wiedswang G, Kvalheim G, Karesen R, Nesland JM, Borresen-Dale AL, Sorlie T (2010)
    Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer (vol 1, pg 160, 2007)
    Mol. Oncol., 4 (2), 169
    DOI 10.1016/j.molonc.2010.01.003
  6. Nesbakken A (2010)
    [Pilonidal disease--an underprioritized disorder]
    Tidsskr Nor Laegeforen, 130 (9), 920
    DOI 10.4045/tidsskr.10.0376, PubMed 20453940
  7. Søvik TT, Irandoust B, Birkeland KI, Aasheim ET, Schou CF, Kristinsson J, Mala T (2010)
    [Type 2 diabetes and metabolic syndrome before and after gastric bypass]
    Tidsskr Nor Laegeforen, 130 (13), 1347-50
    DOI 10.4045/tidsskr.09.0935, PubMed 20596116
  8. Van Belle V, Van Calster B, Brouckaert O, Vanden Bempt I, Pintens S, Harvey V, Murray P, Naume B, Wiedswang G, Paridaens R, Moerman P, Amant F, Leunen K, Smeets A, Drijkoningen M, Wildiers H, Christiaens MR, Vergote I, Van Huffel S, Neven P (2010)
    Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5 years after breast cancer diagnosis
    J Clin Oncol, 28 (27), 4129-34
    DOI 10.1200/JCO.2009.26.4200, PubMed 20713855

 

 
Scroll to top